Introduction: Chromosomal instability and haploinsufficient tumor suppressors DNA replication and chromosomal segregation occur with remarkable fidelity at all levels of complexity, from a fertilized egg through to the billions of cells in adult mammals. However, errors do occur and can lead to aneuploidy, chromosome breaks and translocations. Chromosomal instability (CIN) is very common in malignant tumors, occurring in B80% of colon cancers (Fernebro et al., 2002) . Mutation of classical tumor suppressor genes follows the Knudsen 2-hit model, whereby loss of the wild-type allele as a 'second hit' frequently results in relaxed cellular growth controls (Knudson, 1971) . Inherited cancer syndromes such as Chk2) and ataxia telangiectasia (ATM) are examples of autosomal recessive mutations in checkpoint proteins that normally delay the cell cycle in response to DNA damage and environmental stresses (Malkin et al., 1990; Bell et al., 1999) . Partial or complete loss of their activities leads to genomic instability, further mutations and cancer (Sherr, 2004) . A weakening of checkpoint controls increases the probability of mitotic errors over multiple cell divisions. Thereafter, progression of benign lesions to malignancy becomes a form of natural selection for cells bearing additional activating mutations in proto-oncogenes and loss of tumor suppressors. Predisposition to CIN also occurs in more subtle forms through partial deficiency in genes controlling the cell cycle. Notably, proteins that affect the sequential expression of cyclins D, E, A, B and activation of their partners Cdks 6, 4, 2, 1 can alter the timing and fidelity of sequential events, including centrosome duplication, spindle assembly, anaphase and cytokinesis (Elledge, 1996) . The Cdk family of Ser/Thr kinases determines the sequential order of cell cycle events, but they are also responsive to inputs from the physical and biochemical environment that can impose delay or arrest (Sherr, 2004) . Polo-like kinases (plks) are components of this complex circuitry and impact multiple steps in cell cycle progression, although much remains to be learned concerning their interacting partners (Blagden and Glover, 2003; Barr et al., 2004) .
Cyclin-dependent kinase inhibitors (CKI) negatively regulate Cdks, generally in response to extrinsic conditions, and thereby delay or suppress cell cycle progression. Mice with a single functional allele of the p21(WAF1/CIP1) or INK4 family members display early cancer development (Jackson et al., 2003) . Similarly, mice heterozygous for the CKI p27
Kip display hypersensitivity to a spectrum of mutagenic agents, producing tumor phenotypes intermediate between that of wild type and null mice (Philipp-Staheli et al., 2001) . However, tumors in the heterozygous mice retain the wild-type allele and p27
Kip protein expression is not silenced, indicating that reduced dosage is sufficient to both enhance initiation and progression to malignancy (Philipp-Staheli et al., 2001; Muraoka et al., 2002 , display further acceleration and increased penetrance of tumor development (Tsai et al., 2002; Bai et al., 2003; Jackson et al., 2003) . Haploinsufficiency for cancer suppression has been observed for the spindle assembly checkpoint protein Mad2, with elderly heterozygote mice showing an increased incidence of cancer, as seems typical for these spindle assembly checkpoint insufficiencies (Michel et al., 2001) . The majority of human cancers show no obvious inheritance pattern, but it appears rather that mildly hypomorphic alleles of genes that encode mitotic regulators may act in combination to increase the probability of chromosomal pathologies and cancer. Furthermore, the aging process involves cumulative oxidative damage to gene promoters (Lu et al., 2004) , and a selective reduction in expression of mitotic regulators and centrosome proteins including cyclins A, B, F and Plk1 (Ly et al., 2000) . In combination, incremental losses in multiple mitotic regulators may dampen the switch-like behavior of cyclin/cdk activation and destruction, thereby increasing the likelihood of mitotic errors and cancers over time. Sak/Plk4 is required for mitotic fidelity, and mice with a single Sak gene display an increased incidence of cancer with advancing age (Ko et al., submitted). Herein we review the current information on Sak kinase structure, function and role in cell cycle control and carcinogenesis.
Sak gene structure
The Sak gene is found on mouse chromosome 3 and human chromosome 4q28, a region that frequently undergoes rearrangement or loss in human cancers, and at a particularly high rate in hepatocellular carcinomas (E70%) (Hammond et al., 1999) . The kinase domain of murine Sak is followed by 660 amino acids containing a single 64 amino-acid polo box (pb) domain at the COOH end (Figure 1a) . The Sak-pb is equally related by phylogenetic comparison to the pb1 and pb2 domains of other plks. The Sak-pb domain ) and the upstream region designated the 'cryptic polo box' (cry-pb) (Sak 596-836 ) are both self-association domains (Leung et al., 2002) . As might be expected, Sak kinase activity is markedly increased by a SakT170D mutation in the T loop, while SakK41M, an inactivating mutation in the ATP-binding domain, eliminates activity ( Figure 1b) .
The kinase domain of Sak is most closely related to that of plks, but Sak appears to have diverged from a primordial plk early in the radiation of metazoans (Fode et al., 1994) . The plk-related genes number 1 in single cell eukaryotes, 3 in C. elegans, 2 in Drosophila and 4 in vertebrates ). This modest expansion of the family may have been driven by the additional complexities of coordinating cell division, polarity and checkpoints in animals. Curiously, plk homologs are absent in Arabidopsis (Initiative, 2000) , suggesting a possible connection with basic structural differences, such as the absence of centrosomes and the presence of a preprophase band that can contribute to spindle and phragmoplast orientation in plants, while yeast and animal cells require additional inputs from spindle poles, the membrane cortex and other extrinsic sources. Mammalian Plk1 and Plk3 functions overlap and are conserved, as expression of either Plk1 or Plk3 in ts cdc5-1 mutant yeast cells rescues the mitotic defects (Ouyang et al., 1997; Lee et al., 1998) . These and other observations suggest that the mitotic functions of Cdc5 may be distributed among the various mammalian plks, thereby affording additional levels of cell cycle control during development. However, Sak expression in ts cdc5-1 cells did not rescue the growth defect, suggesting a nonredundant role for Sak kinase. Furthermore, pb domain swaps between Cdc5 or Plk1 and Sak did not permit rescue of cdc5-1 mutant cells (Hudson and Dennis, unpublished results) .
The C-terminus of Sak contains 3 PEST sequences, which are commonly associated with reduced protein Plk4 and mitotic fidelity CJ Swallow et al stability, and indeed Sak protein displayed a short halflife (2-3 h) in nonsynchronized cells (Fode et al., 1996) . Sak protein is ubiquitinated and destroyed by the anaphase-promoting complex (APC/C) following mitotis, similar in this regard to Cdc5 (Shirayama et al., 1998) , and Plk1 (Lindon and Pines, 2004) . The removal of PEST sequences from Sak enhances the stability of the protein (Yamashita et al., 2001) . Tec tyrosine kinase binds to the cry-pb, stabilizes the protein by protecting it from PEST-dependent proteolysis, and enhances phosphorylation of the Sak kinase domain (Yamashita et al., 2001) . Tec tyrosine kinases are activated downstream of many cell-surface receptors, and influence a range of signaling, including pathways that regulate cytoskeletal reorganization and cell motility (Lucas et al., 2003) . Tec and Sak kinases are both highly expressed in lymphoma cells where they may interact to regulate substratumindependent growth (Fode et al., 1994) .
Sak expression
Expression of Sak at the mRNA and protein levels is cell cycle regulated, in a pattern similar to other plk family members (Fode et al., 1996) . Sak expression in cells released from serum starvation is low in G 1 , increases in S through G 2 , and peaks in M phase (Fode et al., 1996) . Similarly, after 70% hepatectomy, Sak transcripts in the regenerating liver increase incrementally from late G 1 through S, peaking at G 2 /M (Ko et al., submitted). Early termination of transcription of the mouse gene, and alternative splicing at exons 5 and 6, results in the Sak-b transcript, which encodes only the kinase domain and a carboxyl end translated from 147-bp of sequence contiguous with exon 5 (Fode et al., 1996) . Sak-b transcripts account for only 5% of the total Sak transcripts in mouse tissues, and have not been detected in human cells or tissues. Human Sak cDNA has an insertion corresponding to an extension of exon 5, which adds the Sak-b carboxy tail into the full-length Sak sequence to produce an insertion of 34 amino acids relative to the mouse Sak-a protein sequence . Exons 5, 6 and 7 of human and mouse Sak are less conserved in cDNA sequence, and appear to encode a peptide sequence that joins functional domains in the protein. Analysis of the murine Sak 5 0 upstream region revealed one major transcription start site at position À303 bp relative to the start of translation, a proximal region for positive regulation at À1 to À454 and a more distal domain effecting negative regulation at À455 to À991 . The factors that directly control Sak transcription during the cell cycle remain to be determined.
Sak protein structure
The X-ray structures of Sak and Plk1 pb domains in isolation reveal six b-strands and an a-strand, but surprisingly, the organization of the strands is markedly different between the two proteins (Leung et al., 2002; Elia et al., 2003) . The Sak-pb (Sak 870-960 ) forms an intermolecular homodimer, in which b-strands 6, 1, 2, and 3 from one monomer form a contiguous antiparallel sheet with b-strands 4 and 5 from the second monomer (Leung et al., 2002) . In contrast, the two pb domains of Plk1 form an intramolecular heterodimer. These distinct Sak and Plk1 pb dimer structures place different sequences in the interior and at the dimer clefts (Elia et al., 2003) . The structure is flipped around such that the residues forming the interface between the pbs in the Sak homodimer are largely at the exterior of the Plk1 pb heterodimer (Elia et al., 2003) . This argues against conservation of a binding site at the dimer interfaces. The positively charged cleft at the pb1-pb2 heterodimer interface of Plk1 binds to phosphopeptides containing SpS/pT-P/X, and thereby docks the protein to specific phosphoproteins on centrioles. The pb dimer of Plk1 binds to the kinase domain in a phospho-independent manner, which blocks the catalytic cleft. Phosphopeptide binding may alter the pb conformation to release the kinase domain, and with the resultant T loop phosphorylation, the kinase becomes activated (Elia et al., 2003) . Attempts to identify synthetic phosphopeptides that bind to recombinant Sak-pb have thus far been unsuccessful (F Sicheri, unpublished observations).
Sak-pb homodimerizes when co-expressed in NIH-3T3 cells as myc-and flag-tagged forms of the protein (Leung et al., 2002) . Both full-length GFP-Sak and GFP-tagged Sak-pb localize to the nucleolus in G 2 phase, to centrosomes in early M, and to the cleavage furrow during telophase . Similarly, localization of Plk1 to mitotic structures is dependent on its two pb domains (Lee et al., 1998) . The subcellular localizations of Plk1 and Sak overlap with the exception that Plk1 is not observed in the nucleolus, while Sak was not found at the centromeres . Sak 596-836 (cry-pb), a region upstream of the Sak-pb domain, has secondary structure motifs with similarity to Sak-pb. Sak cry-pb also functions as a self-association domain as well as binding to the Sak kinase domain,but not to the Sak-pb (Leung et al., 2002) . GFP-Sak cry-pb localized to centrosomes, and current efforts are directed at solving the structure of this domain (G Leung and F Sicheri, personal communication) . It is possible that fulllength Sak dimerizes through both the Sak cry-pb and the Sak-pb domains, thereby forming two unique interfaces that may function as interaction domains. Dimerization of each domain could be independently regulated to allow multiple upstream inputs to Sak kinase activity and localization. We have found that Sak-pb is necessary but not sufficient for Sak binding to p53, suggesting that interactions between the subdomains of Sak are important for binding (Figure 1c ).
Sak-deficient embryos
We generated a targeted mutation in ES cells that deleted the start of translation as well as part of the Sak Plk4 and mitotic fidelity CJ Swallow et al kinase domain . Sak À/À embryos lack Sak protein and arrest at BE7.5, shortly after gastrulation and prior to somite and neural tube formation. Sak À/À embryos showed a high fraction of cells in mitosis, and many of the mitotic figures displayed a morphology similar to that described for Cdc5-1 mutant yeast cells, with partially segregated chromosomes (Hartwell et al., 1973; Sharon and Simchen, 1990) . Sak À/À blastocyst explants also arrested with a marked accumulation of phosphorylated histone H3 and cyclin B1 positive cells, indicating an anaphase block. In addition, Sak À/À blastocyst cultures displayed a marked increase in dumbbell-shaped cells blocked in telophase. Apoptotic cells in the Sak À/À embryos were increased 20-fold, a phenotype also observed in E6.5 Mad2 À/À embryos, which are defective in the spindle assembly checkpoint (Michel et al., 2001) . The cellular phenotype in Sak À/À embryos can be summarized as a late mitotic delay causing a high rate of apoptosis, and ultimately embryo death.
Sak was the first mammalian plk to be mutated at the whole organism level. Recently, Plk2/Snk-deficient mice were reported to be normal for postnatal growth, but skeletal development and placental growth was slower during gestation (Yarm, 2002) . Plk2/Snk is an earlyresponse gene expressed at G 1 in cultured cells, and Plk2 À/À MEFs are delayed at G 1 /S and grow slowly. Plk2/Snk transcripts are found mainly in the hippocampal neurons of adult rodent brains, a more restricted profile than other plks. Nonetheless, the Plk2 À/À MEF slow-growth phenotype suggests a role in cell cycle regulation, which is likely more context-dependent than that of Sak. Sak À/À mouse embryos proceed through many cell divisions before arresting, which suggests that Sak may be redundant or maternally supplied at early stages of embryogenesis. The former explanation seems more likely, as Sak turns over completely with each cell cycle in cultured fibroblasts. Alternatively, Sak may not be required until morphogenesis begins in the embryo at BE6.5. Another possibility is that defective mitosis does occur in early Sak À/À embryos, but checkpoints are absent and apoptosis is delayed until after gastrulation. The cell cycle and notably the mitotic exit network has certain unique features in the early embryo. For example, in the Drosophila syncytium, only partial destruction of cyclin B at spindle poles and centromeres occurs between mitoses, but with cellularization of the embryo, destruction of cyclin B is nearly complete between cell cycles (Su et al., 1998) . In early Drosophila and Xenopus embryogenesis, mitotic exit depends only on fizzy (Cdc20), while fizzy-related (Cdh1) is not expressed until the larval stage of development, when APC-Cdh1 is required for complete destruction of mitotic cyclins (Sigrist and Lehner, 1997; Brassac et al., 2000) . In this regard, cell division occurs until the postgastrula stage in Sak À/À embryos, at which point cyclin B1 persists and late anaphase arrest is evident, suggesting that APC-Cdh1 activity may be insufficient. Mammalian Cdc14a is reported to dephosphorylate Cdh1, and thereby increase APC-Cdh1 but not APCCdc20 activity (Bembenek and Yu, 2001 ). In yeast, Cdc5 phosphorylates Cdc14 leading to release of Cdc14 from the nucleolus, which stimulates the mitotic exit network during late anaphase (Visintin et al., 2003) .
The requirement for Sak in the postgastrula mammalian embryo may involve placement of the spindle poles and cleavage furrow in relation to cortical cues, and a resultant impact on tissue morphogenesis. Sak is highly expressed in ciliated epithelium of the nasal cavity and large airways of the late stage embryo, which unlike other sites of Sak expression, are not proliferating cells (Fode et al., 1994) . A common feature of ciliated and dividing cells is the motile nature of microtubules, which radiate from centrioles and mark the polarity of cell. Transient overexpression of Sak in fibroblasts resulted in an enlarged, flattened morphology, and rapid loss of viability after 48 h (Fode et al., 1996) .
Sak and cancer in mice
Sak mRNA and protein are present in Sak þ /À MEFs at B50% the level found in Sak þ / þ MEFs. Sak þ /À MEFs display a phenotype of slower growth as well as an increased incidence of centrosome amplification and abnormal spindles, compared to Sak þ / þ MEFs (Ko et al., submitted). Furthermore, heterozygous Sak mice on a CD1 background developed cancer at a variety of primary sites with age, most strikingly the liver and the lung (Ko et al., submitted). The liver tumors are multifocal, high grade and display prominent mitotic irregularities. An analysis of four extragenic polymorphic microsatellite markers in the region immediately flanking the Sak gene revealed no loss of heterozygosity in liver tumor tissue compared to adjacent noncancerous liver in 10 mice, and Sak expression was preserved at both the mRNA and protein levels in the tumors. By applying the mitogenic stimulus of partial hepatectomy (PH), we observed an increased incidence and reduced latency of hepatocellular carcinogenesis in Sak þ /À mice (Ko et al., submitted). An examination of the regenerating liver revealed a B4 h delay in the first mitotic division and a marked increase in multipolar spindles at 40-44 h. Strikingly, the sharpness of cyclin B1 accumulation and destruction in the first cell cycle after PH was diminished in Sak þ /À mice (Figure 2a) . Similarly, in Sak þ /À MEFs, the rise and fall of cyclin B1 after release from serum starvation was flattened and extended ( Figure 2b ). Taken together, our data demonstrate that Sak is haploinsufficient for tumor suppression, comparable in this regard to Mad2, BubR1 and p27
Kip (Michel et al., 2001; Philipp-Staheli et al., 2001; Dai et al., 2004) .
The Sak þ /À MEFs also display a weakened mitotic checkpoint when treated with nocodazole, as well as centrosome hyperamplification, similar in this regard to p53 and p21
Cip1 deficient MEFs . Prolonged activation of cyclinE/Cdk2 also causes centrosome amplification and multipolar spindles, thereby disrupting chromosome segregation. In late G 1/ S, Cdk2/cyclinE phosphorylates nucleophosmin, a negative regulator of centrosome duplication, thus causing its release from centrosomes and stimulation of centrosome duplication . Interestingly, centrosome duplication is also stimulated by phosphorylation of nucleophosmin at Ser-4 by Plk1 (Zhang et al., 2004) . We are currently examining the interaction between Sak and p53 as well as other effectors to determine how Sak influences multiple events during cell cycle progression.
The Sak þ /À liver architecture was poorly organized compared to that of Sak þ / þ animals 7 days after PH, by which time normal liver mass had been restored in both genotypes (Figure 3) . Three-dimensional organization of hepatocytes following PH may be dependent on spindle placement and orientation during mitosis. A certain dynamic instability of microtubule asters radiating from spindle poles may allow precise positioning of the mitotic apparatus and the cleavage furrow. Microtubules are oriented with their (À) end at the centrosomes and ( þ ) end pointing towards the cortex. The fibers undergo phases of shortening and growth, a dynamic instability that allows an iterative process of pattern formation at the cellular level during cell movement, cell division and morphogenesis. Plk1 is known to interact with katanin, the microtubule-severing protein (McNally et al., 2002) , as well as with microtubule stabilizing and destabilizing proteins (TCTP and Stathmin, respectively) (Budde et al., 2001; Yarm 2002 ). In C. elegans, Plx1 has been shown to increase the microtubule-severing activity of katanin in vitro (McNally et al., 2002) . Therefore, we are investigating the possibility that Sak plays a role in microtubule remodeling and spindle placement in animal tissues.
Sak expression in human cancer
Sak expression is apparent only in proliferating cells, and correlates with proliferative index (Fode et al., 1994; Macmillan et al., 2001) . However, Sak transcripts were only modestly increased in human colorectal cancer tissue (T), as compared with adjacent normal mucosa (NM) (T : NM ratio of 1.3170.10, mean7s.e.m., n ¼ 71) . Analysis of Plk1 transcripts in the same specimens showed a mean T : NM ratio of 1.6270.13, consistent with reports of Plk1 overexpression in colorectal and other primary cancers (Wolf et al., 1997; Macmillan et al., 2001; Takahashi et al., 2003) . Interestingly, a small group of colorectal cancer patients showed Sak transcript levels more than 2SD below the mean, without an associated reduction in Plk1 expression. The latter finding is more analogous to Plk3 expression in human cancer, which is reduced compared to normal tissues, particularly in lung and head and neck cancers (Wolf et al., 1997; Dai et al., 2000) . We have recently identified an even higher rate of reduced Sak expression in human hepatoma, in which preliminary analysis also indicates frequent loss of heterozygosity (E70%) close to the Sak gene locus (Ko et al., submitted) . This is consistent with the high rates of 4q loss reported in hepatoma, and also in head and neck squamous cell carcinomas. Since Sak is haploinsufficient to suppress spontaneous hepatoma hepatocytes in anaphase were larger and displayed frequent aberrant mitotic spindles. Examples of mitotic figures are indicated (arrows). At 7 days PH (lower panels), sinusoidal architecture and hepatocyte organization was distorted in Sak þ /À mice, although liver volume was comparable to that of wild-type littermates development in mice, the reduced Sak expression we have observed in human tumors could contribute to carcinogenesis. Reduced Sak function could also arise through sequence changes that render the protein unstable, as with Plk1 (Simizu and Osada, 2000) , decrease kinase activity, weaken interaction with binding partners, or cause mislocalization. Further analysis of the Sak gene in human cancer patients may reveal such changes.
Sak transcript levels in colorectal tumors relative to paired normal mucosa were significantly higher in patients over 60 compared to less than 60 years of age . The difference was due to both a significant decrease in Sak expression in normal mucosa as well as an increase in expression in colorectal tumors with age. A decline in Sak expression with age is not unexpected in light of the decrease in other cell cycle genes previously shown in fibroblast cell lines derived from donors of increasing age, in particular Plk1 (Ly et al., 2000) . The resultant loss of precision in timing of cell cycle events in all probability contributes to the increased incidence of cancer with age. Sak expression did not correlate with stage of colorectal cancer, suggesting that loss of Sak is not simply a result of cancer progression.
Sak and CIN
Our studies in Sak þ /À mice and MEFs indicate that Sak gene dosage is critical to chromosomal stability. We examined the association between Sak mRNA expression and genomic instability in 13 human colorectal cancer cell lines previously characterized as exhibiting CIN (n ¼ 8 lines) or microsatellite instability (MIN, n ¼ 5 lines) ( Table 1) . Mean SAK expression was significantly lower in the CIN lines (0.79770.083) than in the MIN lines (1.03770.043) (P ¼ 0.029) (Macmillan and Swallow, unpublished results) . Furthermore, two of the three CIN lines with the lowest Sak expression demonstrated only one copy of Sak on FISH analysis (Table 1) . In contrast to Sak, there was no significant difference in Plk1 expression between the CIN and MIN lines (1.44670.140 versus 1.62870.211) (P ¼ 0.49). We pursued this further by classifying the colorectal cancers we had previously tested as either MIN or CIN, based on microsatellite instability at the BAT-26 locus. Mirroring the cell line data, Sak expression was lower in the CIN than the MIN tumors (P ¼ 0.06), while Plk1 was the same between the two groups (P ¼ 0.69). Although retrospective studies of human cancer patients are correlative at best, the cancer phenotype in Sak þ /À mice strongly supports the concept that insufficient Sak, in the absence of other abnormalities, can cause CIN.
Future directions
The macroevents marking the cell cycle, such as equitable segregation of chromosomes, are discrete, and errors can become heritable if the cells survive. The highly cooperative feedback controls on cell cycle progression provide robust properties (Xiong and Ferrell, 2003) . These are regulatory features of the system that enhance cell survival under different conditions. Robustness in cell cycle regulation also implies that incremental changes in the activity of one or more regulatory proteins can be tolerated, possibly causing delays, yet the cell cycle still proceeds with sufficient accuracy for survival of populations. Positive and double-negative feedback loops, for example regulation of/by Cdc2 of/by Cdc25, Cdc2 of/by Wee1 and Plk1 of/by Cdc2, as described by Ferrell (2002) , make the kinase and APC/C networks switch-like, and ensure discrete biochemical states and irreversible transitions. Many mitotic regulators appear to be haploinsufficient for tumor suppression, suggesting that various combinations of naturally occurring hypomorphic alleles and age-related losses in gene expression may be a common route to cancer. Reduced activity of proteins that regulate the Cdks may reduce biochemical cooperativity, leading to inappropriate Cdk activation and/or destruction, and thereby increase the probability of mitotic errors. For example, the failure in Sak þ /À mice of cyclinE/Cdk2 and/or cyclin B1/Cdk1 to attain the sharp peak levels required for proper centrosome duplication and/or chromosome segregation may lead to heritable errors.
Our results suggest that tissues in the embryo and adult Sak þ /À mice may tolerate a certain amount of variance in mitotic regulation, but the lifetime probability that a rare mitotic error becomes a significant event causing cancer increases exponentially with age, particularly when coupled with the highly selective cellular processes that enhance growth autonomy in cancers. Therefore, incremental differences in biochemical activities causing small increases in the probability of mitotic error can in theory markedly decrease the thresholds for pathology when magnified by clonal expansion and selection of cells that gain growth autonomy. To understand the contribution of mitotic regulators to cancer development, we require detailed models of the molecular circuitry, and their effects either 
